When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis

被引：42
|
作者：
Prince, F. H. M. [1 ]
Twilt, M. [1 ,2 ]
Simon, S. C. M. [1 ]
van Rossum, M. A. J. [3 ,4 ]
Armbrust, W. [5 ]
Hoppenreijs, E. P. A. H. [6 ]
Kamphuis, S. [1 ]
van Santen-Hoeufft, M. [7 ]
Koopman-Keemink, Y. [8 ]
Wulffraat, N. M. [9 ]
ten Cate, R. [2 ]
van Suijlekom-Smit, L. W. A. [1 ]
机构：
[1] Sophia Childrens Univ Hosp, Erasmus MC, Dept Paediat Paediat Rheumatol, NL-3000 CB Rotterdam, Netherlands
[2] Leiden Univ, Med Ctr, Dept Paediat Paediat Rheumatol, Leiden, Netherlands
[3] Emma Childrens Hosp AMC, Dept Paediat Paediat Rheumatol, Amsterdam, Netherlands
[4] Jan van Breemen Inst, Amsterdam, Netherlands
[5] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Paediat Paediat Rheumatol, Groningen, Netherlands
[6] Univ Nijmegen, Med Ctr Radboud, Dept Paediat Paediat Rheumatol, Nijmegen, Netherlands
[7] Maastricht Univ, Med Ctr, Dept Internal Med, Subdiv Rheumatol, Maastricht, Netherlands
[8] Hagaziekenhuis Juliana Childrens Hosp, Dept Paediat, The Hague, Netherlands
[9] Utrecht MC Wilhelmina Childrens Hosp, Dept Paediat Paediat Rheumatol, Utrecht, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2009年 / 68卷 / 07期
关键词：
CLINICAL REMISSION; SELECT CATEGORIES; REGISTER; CRITERIA;
D O I：
10.1136/ard.2008.101030
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1228 / 1229
页数：2
相关论文
共 50 条
  • [31] Adherence to biological treatment, etanercept or infliximab in juvenile idiopathic arthritis
    Tynjala, Pirjo
    Vahasalo, Paula
    Lahdenne, Pekka
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 : 27 - 27
  • [32] Factors Associated With Treatment Response to Etanercept in Juvenile Idiopathic Arthritis
    Otten, Marieke H.
    Prince, Femke H. M.
    Armbrust, Wineke
    ten Cate, Rebecca
    Hoppenreijs, Esther P. A. H.
    Twilt, Marinka
    Koopman-Keemink, Yvonne
    Gorter, Simone L.
    Dolman, Koert M.
    Swart, Joost F.
    van den Berg, J. Merlijn
    Wulffraat, Nico M.
    van Rossum, Marion A. J.
    van Suijlekom-Smit, Lisette W. A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (21): : 2340 - 2347
  • [33] Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis
    Jens Klotsche
    Ariane Klein
    Martina Niewerth
    Paula Hoff
    Daniel Windschall
    Ivan Foeldvari
    Johannes-Peter Haas
    Gerd Horneff
    Kirsten Minden
    Arthritis Research & Therapy, 23
  • [34] Re-treatment with etanercept is as effective as the initial firstline treatment in patients with juvenile idiopathic arthritis
    Klotsche, Jens
    Klein, Ariane
    Niewerth, Martina
    Hoff, Paula
    Windschall, Daniel
    Foeldvari, Ivan
    Haas, Johannes-Peter
    Horneff, Gerd
    Minden, Kirsten
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [35] Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis (JIA) patients
    South-Wood, Taunton
    Cummins, Carole
    Cotter, Catherine
    Rahman, Joy
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S943 - S944
  • [36] DEVELOPMENT OF INFLAMMATORY BOWEL DISEASE DURING TREATMENT WITH ETANERCEPT IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
    Krol, Roline
    Swart, Joost F.
    Giancane, Gabriella
    De Roock, Sytze
    Herlin, Troels
    Dolezalova, Pavla
    Sanner, Helga
    Susic, Gordana
    Sztajnbok, Flavio R.
    Maritsi, D.
    Constantin, Tamas
    Vargova, V.
    Sawhney, Sujata
    Rygg, Marite
    Oliveira, Sheila Knupp D. E.
    Cattalini, Marco
    Nordal, Ellen
    Magalhaes, Claudia
    Martini, Alberto
    Wulffraat, Nico
    Ruperto, Nicolino
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 100 - 101
  • [37] TNF and LT binding capacities in the plasma of arthritis patients:: Effect of etanercept treatment in juvenile idiopathic arthritis
    Gudbrandsdottir, S
    Larsen, R
    Sorensen, LK
    Nielsen, S
    Hansen, MB
    Svenson, M
    Bendtzen, K
    Müller, K
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (01) : 118 - 124
  • [38] Combination therapy with etanercept and methotrexate compared to etanercept monotherapy in patients with juvenile idiopathic arthritis
    Horneff, G
    Girschick, H
    Foeldvari, I
    Michels, H
    Rogalski, B
    Schmeling, H
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S724 - S725
  • [39] Etanercept concentration and immunogenicity do not influence the response to Etanercept in patients with juvenile idiopathic arthritis
    Bader-Meunier, Brigitte
    Krzysiek, Roman
    Lemelle, Irene
    Pajot, Christine
    Carbasse, Aurelia
    Poignant, Sylvaine
    Melki, Isabelle
    Quartier, Pierre
    Choupeaux, Laure
    Henry, Elodie
    Treluyer, Jean-Marc
    Belot, Alexandre
    Hacein-Bey-Abina, Salima
    Urien, Saik
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 48 (06) : 1014 - 1018
  • [40] Bone mineral density in children with juvenile idiopathic arthritis after one year of treatment with etanercept
    Susic, Gordana
    Atanaskovic, Marija
    Stojanovic, Roksanda
    Radunovic, Goran
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2018, 146 (5-6) : 297 - 302
12345